AKT1 and hepatocellular carcinoma: In hepatocellular carcinoma and breast cancer, NKAP promotes the proliferation and invasion of tumor cells through the AKT/mammalian target of the rapamycin signaling pathway (Liu et al., 2018; Song et al., 2019).